Mechanisms of Cardiovascular Disease in Accelerated Aging Syndromes

In the past several years, remarkable progress has been made in the understanding of the mechanisms of premature aging. These rare, genetic conditions offer valuable insights into the normal aging process and the complex biology of cardiovascular disease. Many of these advances have been made in the most dramatic of these disorders, Hutchinson–Gilford progeria syndrome. Although characterized by features of normal aging such as alopecia, skin wrinkling, and osteoporosis, patients with Hutchinson–Gilford progeria syndrome are affected by accelerated, premature arteriosclerotic disease that leads to heart attacks and strokes at a mean age of 13 years. In this review, we highlight recent advances in the biology of premature aging uncovered in Hutchinson–Gilford progeria syndrome and other accelerated aging syndromes, advances that provide insight into the mechanisms of cardiovascular diseases ranging from atherosclerosis to arrhythmias.

[1]  T. Shimi,et al.  Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging , 2007, Proceedings of the National Academy of Sciences.

[2]  Francis S. Collins,et al.  A lamin A protein isoform overexpressed in Hutchinson–Gilford progeria syndrome interferes with mitosis in progeria and normal cells , 2007, Proceedings of the National Academy of Sciences.

[3]  A. Jauch,et al.  Telomere dysfunction as a cause of genomic instability in Werner syndrome , 2007, Proceedings of the National Academy of Sciences.

[4]  V. Bohr,et al.  The role of WRN in DNA repair is affected by post-translational modifications , 2007, Mechanisms of Ageing and Development.

[5]  J. Hoeijmakers,et al.  A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis , 2006, Nature.

[6]  Francis S. Collins,et al.  Human laminopathies: nuclei gone genetically awry , 2006, Nature Reviews Genetics.

[7]  R. Hennekam.  Hutchinson–Gilford progeria syndrome: Review of the phenotype , 2006, American journal of medical genetics. Part A.

[8]  V. Andrés,et al.  Telomere Biology and Cardiovascular Disease , 2006, Circulation research.

[9]  Y. Zou,et al.  DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A , 2006, Journal of Cell Science.

[10]  John F. Robinson,et al.  Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles , 2006, Journal of Human Genetics.

[11]  S. Ellard,et al.  The laminopathies: a clinical review , 2006, Clinical genetics.

[12]  J. Campisi,et al.  Ageing: Balancing regeneration and cancer , 2006, Nature.

[13]  Richard T. Lee,et al.  Lamins A and C but Not Lamin B1 Regulate Nuclear Mechanics* , 2006, Journal of Biological Chemistry.

[14]  F. Collins,et al.  Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Levy,et al.  Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study , 2006, Aging cell.

[16]  A. Weiss,et al.  Aggrecan expression is substantially and abnormally upregulated in Hutchinson–Gilford Progeria Syndrome dermal fibroblasts , 2006, Mechanisms of Ageing and Development.

[17]  M. Bergo,et al.  A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. , 2006, The Journal of clinical investigation.

[18]  M. Blasco,et al.  Mice Deficient in Telomerase Activity Develop Hypertension Because of an Excess of Endothelin Production , 2006, Circulation.

[19]  P. Kirkpatrick,et al.  Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis: Effects of Telomerase and Oxidative Stress , 2006, Circulation research.

[20]  Paul Tempst,et al.  The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36 , 2006, Nature.

[21]  T. Misteli,et al.  Distinct structural and mechanical properties of the nuclear lamina in Hutchinson–Gilford progeria syndrome , 2006, Proceedings of the National Academy of Sciences.

[22]  J. Broers,et al.  Nuclear lamins: laminopathies and their role in premature ageing. , 2006, Physiological reviews.

[23]  V. Parnaik,et al.  Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci , 2006, Journal of Cell Science.

[24]  B. Kennedy,et al.  Stabilization of the Retinoblastoma Protein by A-Type Nuclear Lamins Is Required for INK4A-Mediated Cell Cycle Arrest , 2006, Molecular and Cellular Biology.

[25]  A. Al Haj Zen,et al.  Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice. , 2006, Atherosclerosis.

[26]  M. Fraga,et al.  Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F. Collins,et al.  Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Markus Schuelke,et al.  The spectrum of WRN mutations in Werner syndrome patients , 2006, Human mutation.

[29]  J. Denecke,et al.  A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson‐Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS , 2006, Human mutation.

[30]  T. Misteli,et al.  Lamin A-Dependent Nuclear Defects in Human Aging , 2006, Science.

[31]  F. Tesson,et al.  Lamin A/C and cardiac diseases , 2006, Current opinion in cardiology.

[32]  E. Delbarre,et al.  The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers. , 2006, Human molecular genetics.

[33]  Stephen G Young,et al.  A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria , 2006, Science.

[34]  J. Sedivy,et al.  Cellular Senescence in Aging Primates , 2006, Science.

[35]  P. Slagboom,et al.  Impact of genetic variations in the WRN gene on age related pathologies and mortality , 2006, Mechanisms of Ageing and Development.

[36]  Richard T. Lee,et al.  Prelamin A and lamin A appear to be dispensable in the nuclear lamina. , 2006, The Journal of clinical investigation.

[37]  É. Thorin,et al.  Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homologue , 2006, Experimental Gerontology.

[38]  M. Brignole,et al.  Case 26-2005: loss of consciousness while jogging. , 2006, The New England journal of medicine.

[39]  Y. Pinto,et al.  Primary prevention of sudden death in patients with lamin A/C gene mutations. , 2006, The New England journal of medicine.

[40]  H. Scherthan,et al.  Nuclear deformation characterizes Werner syndrome cells , 2005, Cell biology international.

[41]  Christopher J. Jones,et al.  Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  Jennifer M. Gardner,et al.  Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. , 2005, The Journal of investigative dermatology.

[43]  G. Novelli,et al.  Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment , 2005, Cellular and Molecular Life Sciences.

[44]  M. W. Glynn,et al.  Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. , 2005, Human molecular genetics.

[45]  Joel H. Janes,et al.  Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference , 2005, Human Genetics.

[46]  M. Gelb,et al.  Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Ignacio Varela,et al.  Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation , 2005, Nature.

[48]  Karen N Conneely,et al.  Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Gelb,et al.  Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R. Hegele,et al.  Genetic and physiological insights into the metabolic syndrome. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[51]  J. Rottman,et al.  Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. , 2005, Human molecular genetics.

[52]  M. Gelb,et al.  Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Howard J Worman,et al.  Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress , 2005, BMC Cell Biology.

[54]  David J. Chen,et al.  Genomic instability in laminopathy-based premature aging , 2005, Nature Medicine.

[55]  C. López-Otín,et al.  Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. , 2005, Human molecular genetics.

[56]  A. Aviv,et al.  Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition , 2005, Circulation.

[57]  N. Maraldi,et al.  Laminopathies: Involvement of structural nuclear proteins in the pathogenesis of an increasing number of human diseases , 2005, Journal of cellular physiology.

[58]  Y. Yamaguchi,et al.  Overexpression of Hyaluronan in the Tunica Media Promotes the Development of Atherosclerosis , 2005, Circulation research.

[59]  M. Patti,et al.  Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome. , 2005, The Journal of pediatrics.

[60]  C. Harris,et al.  p53 modulates RPA-dependent and RPA-independent WRN helicase activity. , 2005, Cancer research.

[61]  F. Tezuka,et al.  Electrophysiological and Histopathological Characteristics of Progressive Atrioventricular Block Accompanied by Familial Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene , 2005, Journal of cardiovascular electrophysiology.

[62]  M. Bergo,et al.  Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Verdun,et al.  Defective Telomere Lagging Strand Synthesis in Cells Lacking WRN Helicase Activity , 2004, Science.

[64]  R. Hennekam,et al.  Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. , 2004, Human molecular genetics.

[65]  S. Benedetti,et al.  Laminopathies: from the heart of the cell to the clinics , 2004, Current opinion in neurology.

[66]  E. Furth,et al.  Telomere Shortening Exposes Functions for the Mouse Werner and Bloom Syndrome Genes , 2004, Molecular and Cellular Biology.

[67]  K. M. Krishnamoorthy,et al.  Hutchinson-Gilford progeria syndrome with severe calcific aortic valve stenosis and calcific mitral valve. , 2004, The Journal of heart valve disease.

[68]  C. Reddel,et al.  Lamin A expression levels are unperturbed at the normal and mutant alleles but display partial splice site selection in Hutchinson-Gilford progeria syndrome , 2004, Journal of Medical Genetics.

[69]  R. Hegele,et al.  Laminopathies and Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[70]  Atul J Butte,et al.  Genome‐scale expression profiling of Hutchinson–Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis , 2004, Aging cell.

[71]  R. DePinho,et al.  Essential role of limiting telomeres in the pathogenesis of Werner syndrome , 2004, Nature Genetics.

[72]  E. Metter,et al.  Werner syndrome protein 1367 variants and disposition towards coronary artery disease in Caucasian patients , 2004, Mechanisms of Ageing and Development.

[73]  Richard L. Frock,et al.  A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Yosef Gruenbaum,et al.  Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson–Gilford progeria syndrome , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Y. Pinto,et al.  Often seen but rarely recognised: cardiac complications of lamin A/C mutations. , 2004, European heart journal.

[76]  V. Bohr,et al.  Junction of RecQ Helicase Biochemistry and Human Disease* , 2004, Journal of Biological Chemistry.

[77]  T. Ogihara,et al.  LMNA mutation in a 45 year old Japanese subject with Hutchinson-Gilford progeria syndrome , 2004, Journal of Medical Genetics.

[78]  K. Wilson,et al.  Proteins that bind A-type lamins: integrating isolated clues , 2004, Journal of Cell Science.

[79]  J. Barrett,et al.  Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks , 2004, Nature Cell Biology.

[80]  Richard T. Lee,et al.  Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. , 2004, The Journal of clinical investigation.

[81]  D. Orren,et al.  TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA , 2004, Oncogene.

[82]  C. Vigouroux,et al.  LMNA mutations in atypical Werner's syndrome , 2003, The Lancet.

[83]  C. Müller,et al.  A synonymous codon change in the LMNA gene alters mRNA splicing and causes limb girdle muscular dystrophy type 1B , 2003, Journal of medical genetics.

[84]  A. K. Agarwal,et al.  Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. , 2003, Human molecular genetics.

[85]  M. Komajda,et al.  Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations , 2003, Journal of medical genetics.

[86]  Pierre Cau,et al.  Lamin A Truncation in Hutchinson-Gilford Progeria , 2003, Science.

[87]  Laura Scott,et al.  Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome , 2003, Nature.

[88]  N. Samani,et al.  White Cell Telomere Length and Risk of Premature Myocardial Infarction , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[89]  Robert M. Bachoo,et al.  Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing , 2003, Nature.

[90]  M. Blasco,et al.  Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation , 2003, The EMBO journal.

[91]  N. van Bruggen,et al.  Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[92]  G. Scarano,et al.  Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. , 2002, American journal of human genetics.

[93]  I. Komuro,et al.  Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction , 2002, Circulation.

[94]  C. López-Otín,et al.  Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase–deficient mice , 2002, Nature Genetics.

[95]  J. Hoeijmakers,et al.  Premature Aging in Mice Deficient in DNA Repair and Transcription , 2002, Science.

[96]  Sui Huang,et al.  Alteration of nuclear lamin organization inhibits RNA polymerase II–dependent transcription , 2002, The Journal of cell biology.

[97]  L. Bonetta.  Edible vaccines: not quite ready for prime time , 2002, Nature Medicine.

[98]  D. Rader,et al.  The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. , 2001, The Journal of clinical investigation.

[99]  C. Stewart,et al.  The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases. , 2001, Trends in cardiovascular medicine.

[100]  C. Stewart,et al.  The Nuclear Envelope in Muscular Dystrophy and Cardiovascular Diseases , 2001, Traffic.

[101]  J. Mendell,et al.  Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy. , 2001, American journal of medical genetics.

[102]  N. Samani,et al.  Telomere shortening in atherosclerosis , 2001, The Lancet.

[103]  B. Delahunt,et al.  Smooth muscle cell depletion and collagen types in progeric arteries. , 2001, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[104]  A. Shimamoto,et al.  Werner helicase relocates into nuclear foci in response to DNA damaging agents and co‐localizes with RPA and Rad51 , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[105]  J. Skurnick,et al.  Telomere Length as an Indicator of Biological Aging: The Gender Effect and Relation With Pulse Pressure and Pulse Wave Velocity , 2001, Hypertension.

[106]  J. Skurnick,et al.  Telomere length inversely correlates with pulse pressure and is highly familial. , 2000, Hypertension.

[107]  F. Baas,et al.  Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). , 2000, Human molecular genetics.

[108]  D. Lockhart,et al.  Mitotic misregulation and human aging. , 2000, Science.

[109]  L. Mestroni,et al.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. , 2000, Circulation.

[110]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[111]  H. Youssoufian,et al.  Werner helicase expression in human fetal and adult aortas , 1999, Experimental Gerontology.

[112]  T. Wight,et al.  Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[113]  Sandy Chang,et al.  Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice , 1999, Cell.

[114]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[115]  P. Leder,et al.  A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[116]  R. DePinho,et al.  Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.

[117]  J. Skurnick,et al.  Shortened telomere length in white blood cells of patients with IDDM. , 1998, Diabetes.

[118]  María A Blasco,et al.  Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.

[119]  R. Goldman,et al.  Disruption of Nuclear Lamin Organization Alters the Distribution of Replication Factors and Inhibits DNA Synthesis , 1997, The Journal of cell biology.

[120]  G. Schellenberg,et al.  Homozygous and compound heterozygous mutations at the Werner syndrome locus. , 1996, Human molecular genetics.

[121]  S Bloom,et al.  Intermediate filament-mediated stretch-induced changes in chromatin: a hypothesis for growth initiation in cardiac myocytes. , 1996, Journal of molecular and cellular cardiology.

[122]  G. Schellenberg,et al.  Positional Cloning of the Werner's Syndrome Gene , 1996, Science.

[123]  L. Gerace,et al.  A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones , 1995, The Journal of cell biology.

[124]  M. Goto,et al.  Hypercoagulable State Indicates an Additional Risk Factor for Atherosclerosis in Werner’s Syndrome , 1995, Thrombosis and Haemostasis.

[125]  M. I. Melaragno,et al.  Cytogenetic aspects of Werner's syndrome lymphocyte cultures , 1995, Mechanisms of Ageing and Development.

[126]  M. Pasic,et al.  Aortic homograft and mitral valve repair in a patient with Werner's syndrome. , 1994, The Annals of thoracic surgery.

[127]  R. Faragher,et al.  The expression of proliferation-dependent antigens during the lifespan of normal and progeroid human fibroblasts in culture. , 1994, Journal of cell science.

[128]  W. Shim,et al.  Cardiovascular findings of Hutchinson-Gilford syndrome--a Doppler and two-dimensional echocardiographic study. , 1993, Yonsei medical journal.

[129]  K. Hasel,et al.  The alpha‐helical rod domain of human lamins A and C contains a chromatin binding site. , 1993, The EMBO journal.

[130]  E. Schönherr,et al.  Deficient expression of decorin in infantile progeroid patients. , 1993, The Journal of biological chemistry.

[131]  M. Clark,et al.  Elevated levels of glycoprotein gp200 in progeria fibroblasts , 1993, Molecular and Cellular Biochemistry.

[132]  J. Roujeau,et al.  Abnormal gene expression in skin fibroblasts from a Hutchinson-Gilford patient. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[133]  B. Labeille,et al.  Increased secretion of fibronectin and collagen by progeria (Hutchinson-Gilford) fibroblasts , 1988, European Journal of Pediatrics.

[134]  J. Davidson,et al.  Increased elastin production by progeria skin fibroblasts is controlled by the steady-state levels of elastin mRNA. , 1988, The Journal of investigative dermatology.

[135]  P. Baker,et al.  Cardiovascular abnormalities in progeria. Case report and review of the literature. , 1981, Archives of pathology & laboratory medicine.

[136]  F L DeBusk,et al.  The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. , 1972, The Journal of pediatrics.

[137]  W. Reichel,et al.  Pathologic findings in progeria: myocardial fibrosis and lipofuscin pigment. , 1970, American journal of clinical pathology.

[138]  W. Yakovac,et al.  Cardiovascular manifestations in progeria. Report of clinical and pathologic findings in a patient with severe arteriosclerotic heart disease and aortic stenosis. , 1962, American heart journal.

[139]  M. Hashem,et al.  Progeria, a pathologic study. , 1960, The Journal of pediatrics.

[140]  R. Agrelo,et al.  A new molecular model of cellular aging based on Werner syndrome. , 2007, Medical hypotheses.

[141]  D. Pennell,et al.  Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[142]  N. Maraldi,et al.  Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies. , 2006, European journal of histochemistry : EJH.

[143]  S. Varnous,et al.  Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. , 2005, Human molecular genetics.

[144]  N. Maraldi,et al.  Implications for nuclear organization and gene transcription of lamin A/C specific mutations. , 2005, Advances in enzyme regulation.

[145]  F. Pallardó,et al.  Multiple Involvement of Oxidative Stress in Werner Syndrome Phenotype , 2005, Biogerontology.

[146]  L. Eckel,et al.  Severe heart valve calcification in a young patient with Werner syndrome. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[147]  R. Schekman,et al.  Mitotic Misregulation and Human Aging , 2000 .

[148]  E. Gilbert-Barness,et al.  Histological and ultrastructural features of atherosclerosis in progeria. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[149]  A. Kupfer,et al.  The processing pathway of prelamin A. , 1994, Journal of cell science.

[150]  H. Hoehn,et al.  Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism. , 1981, Cytogenetics and cell genetics.